Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...
A Review of Legacy: a Black Physician Reckons With Racism in Medicine by Dr. Uché Blackstock Ethnic and racial disparities in ...
American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...
Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...
Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...
FOX 7 Austin KTBC on MSN3d
Cancer death rates have dropped in the U.S.: reportThe American Cancer Society is out with its 2025 Cancer Facts and Figures report. FOX 7 Austin's Rebecca Thomas spoke with an ...
The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
Diabetes and hypertension are the commonest causes of kidney damage and it is essential to know about the common symptoms of kidney dysfunction as below. Some common symptoms of kidney damage are ...
Feb. 18, 2025 — The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback